Literature DB >> 2076039

Antibodies to microfilarial sheath in bancroftian filariasis--prevalence and characterization.

B Ravindran1, A K Satapathy, M K Das, N M Pattnaik, V R Subramanyam.   

Abstract

Antibodies directed towards the sheaths of microfilariae have been implicated in the elimination of circulating microfilariae, both in experimental and human filariasis. In the present study antisheath antibodies have been detected in human sera by indirect immunoperoxidase assay (IPA) using fixed Wuchereria bancrofti microfilariae as antigen. One hundred and eighteen sera collected from an area endemic for Bancroftian filariasis were tested. While 80% of sera from microfilariae carriers had no demonstrable antisheath antibodies, more than 80% of amicrofilaraemic samples (chronic filariasis cases and endemic normals) had antisheath antibodies. The antibody activity was found in IgG, IgM and also IgE isotypes. IgG subclass typing with monospecific antisera revealed significantly higher antisheath activity in IgG2 in comparison with other IgG subclasses. The determinants on sheathed microfilariae reacting with antisheath antibodies were found to be thermostable (100 degrees C for 30 minutes), resistant to protease treatment and significantly sensitive to sodium periodate treatment, indicating the possible role of carbohydrate moieties in eliciting protective antisheath antibodies in Bancroftian filariasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076039     DOI: 10.1080/00034983.1990.11812516

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  2 in total

1.  Human bancroftian filariasis - a role for antibodies to parasite carbohydrates.

Authors:  M C Mohanty; A K Satapathy; P K Sahoo; B Ravindran
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Slide enzyme-linked immunosorbent assay for the diagnosis of Babesia bigemina infection in bovines.

Authors:  R Ravindran; A K Mishra; J R Rao
Journal:  Vet Res Commun       Date:  2007-02-06       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.